Back

Cancer-myeloid cell invasive program in pediatric-type diffuse high-grade glioma

Ruiz Moreno, C.; Collot, R.; van den Broek, T. J. M.; Wehrens, E. J.; Bessler, N.; Dharmadhikari, G.; te Pas, B. M.; Ibarra, I. L.; Metselaar, D. S.; Kranendonk, M. E. G.; Hoving, E. W.; van der Lugt, J.; Calkoen, F.; Zomer, A.; Theis, F.; Hulleman, E.; van Vuurden, D. G.; Rios, A. C.; Stunnenberg, H. G.

2026-01-25 cancer biology
10.64898/2026.01.23.701142 bioRxiv
Show abstract

Pediatric-type diffuse high-grade gliomas (pHGGs) are aggressive, heterogeneous brain tumors shaped by intricate cancer-microenvironment cell-cell interactions. Here, we present an integrative multimodal pHGGmap, encompassing over 800,000 cells from 136 patients profiled across transcriptomic, epigenomic, and spatial modalities. Its analysis delineated robust cancer-myeloid cell programs that structured the tumor ecosystem and identified ten distinct cancer cell states, including previously unrecognized developmental and context-responsive programs. Among these, radial glial-like (RG-like) cells exhibited dual stress-adapted and infiltrative phenotypes. Tumor-associated monocyte-derived macrophages and resident microglia engaged in four distinct immunomodulatory programs aligned with specific cancer states. Three conserved multicellular communities were maintained across treatment, including a stable, spatially and transcriptionally linked RG-like/complement-macrophage niche, indicative of cellular co-option and adaptation to support invasion. Longitudinal profiling of a metastatic diffuse midline glioma case showed that RG-like cells predominate during dissemination and remain associated with complement-enriched macrophages, whose reprogramming restores immune activation. pHGGmap establishes a landmark resource for translational discovery. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=183 SRC="FIGDIR/small/701142v1_ufig1.gif" ALT="Figure 1"> View larger version (54K): org.highwire.dtl.DTLVardef@7ae699org.highwire.dtl.DTLVardef@b95b92org.highwire.dtl.DTLVardef@12adcf9org.highwire.dtl.DTLVardef@1118703_HPS_FORMAT_FIGEXP M_FIG C_FIG

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Cancer Cell
38 papers in training set
Top 0.1%
12.0%
2
Nature Communications
4913 papers in training set
Top 19%
9.8%
3
Neuro-Oncology
30 papers in training set
Top 0.1%
8.9%
4
Genome Medicine
154 papers in training set
Top 0.7%
8.2%
5
Cell Reports
1338 papers in training set
Top 5%
7.0%
6
Cell Reports Medicine
140 papers in training set
Top 0.5%
6.2%
50% of probability mass above
7
Cell Genomics
162 papers in training set
Top 0.9%
4.7%
8
Cancer Research
116 papers in training set
Top 0.6%
4.2%
9
Advanced Science
249 papers in training set
Top 6%
3.5%
10
eLife
5422 papers in training set
Top 43%
1.7%
11
Nature Genetics
240 papers in training set
Top 4%
1.7%
12
Nature
575 papers in training set
Top 11%
1.6%
13
Cell
370 papers in training set
Top 13%
1.3%
14
Neuro-Oncology Advances
24 papers in training set
Top 0.3%
1.3%
15
Clinical Cancer Research
58 papers in training set
Top 1%
1.2%
16
Nature Cancer
35 papers in training set
Top 1%
1.2%
17
Cancer Discovery
61 papers in training set
Top 1%
1.1%
18
Cell Reports Methods
141 papers in training set
Top 4%
1.1%
19
npj Systems Biology and Applications
99 papers in training set
Top 2%
0.9%
20
Genome Biology
555 papers in training set
Top 7%
0.9%
21
Cell Systems
167 papers in training set
Top 11%
0.8%
22
Journal of Clinical Investigation
164 papers in training set
Top 6%
0.8%
23
Molecular Cancer
14 papers in training set
Top 0.9%
0.8%
24
npj Precision Oncology
48 papers in training set
Top 1%
0.7%
25
Cell Stem Cell
57 papers in training set
Top 2%
0.7%
26
Communications Biology
886 papers in training set
Top 30%
0.6%